Alnylam Pharmaceuticals
ALNY
#566
Rank
$41.74 B
Marketcap
$314.80
Share price
-1.75%
Change (1 day)
28.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company